Metastatic Osteosarcoma clinical trials at UCLA
1 in progress, 0 open to eligible people
Showing trials for
SARC038: Phase 2 Study of Regorafenib and Nivolumab in Osteosarcoma
Sorry, in progress, not accepting new patients
A phase 2 study of regorafenib in combination with nivolumab in patients with refractory or recurrent osteosarcoma.
Los Angeles, California and other locations
Our lead scientists for Metastatic Osteosarcoma research studies include Noah Federman.
Last updated: